Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis

References

• Planell N, Lozano JJ, Mora-Buch R, et al. Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations. Gut. 2013;62(7):967–976. doi:10.1136/gutjnl-2012-303333
   PubMed Web of Science ®Google Scholar
• Arkteg CB, Goll R, Gundersen MD, Anderssen E, Fenton C, Florholmen J. Mucosal gene transcription of ulcerative colitis in endoscopic remission. Scand J Gastroenterol. 2020;55(2):139–147. doi:10.1080/00365521.2019.1710245
   PubMed Web of Science ®Google Scholar
• Bjerrum JT, Hansen M, Olsen J, Nielsen OH. Genome-wide gene expression analysis of mucosal colonic biopsies and isolated colonocytes suggests a continuous inflammatory state in the lamina propria of patients with quiescent ulcerative colitis. Inflamm Bowel Dis. 2010;16(6):999–1007. doi:10.1002/ibd.21142
   PubMed Web of Science ®Google Scholar
• Fenton CG, Taman H, Florholmen J, Sorbye SW, Paulssen RH. Transcriptional Signatures That Define Ulcerative Colitis in Remission. Inflamm Bowel Dis. 2021;27(1):94–105. doi:10.1093/ibd/izaa075
   PubMed Web of Science ®Google Scholar
• Mitsialis V, Wall S, Liu P, et al. Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn’s Disease. Gastroenterology. 2020;159(2):591–608 e510. doi:10.1053/j.gastro.2020.04.074
   PubMed Web of Science ®Google Scholar
• Peluso I, Pallone F, Monteleone G. Interleukin-12 and Th1 immune response in Crohn’s disease: pathogenetic relevance and therapeutic implication. World J Gastroenterol. 2006;12(35):5606–5610. doi:10.3748/wjg.v12.i35.5606
   PubMed Web of Science ®Google Scholar
• Li J, Ueno A, Fort Gasia M, et al. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn’s Disease. Inflamm Bowel Dis. 2016;22(8):1779–1792. doi:10.1097/MIB.0000000000000811
   PubMed Web of Science ®Google Scholar
• Fujino S, Andoh A, Bamba S, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut. 2003;52(1):65–70. doi:10.1136/gut.52.1.65
   PubMed Web of Science ®Google Scholar
• Nielsen OH, Kirman I, Rudiger N, Hendel J, Vainer B. Upregulation of interleukin-12 and −17 in active inflammatory bowel disease. Scand J Gastroenterol. 2003;38(2):180–185. doi:10.1080/00365520310000672
   PubMed Web of Science ®Google Scholar
• Sugihara T, Kobori A, Imaeda H, et al. The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease. Clin Exp Immunol. 2010;160(3):386–393. doi:10.1111/j.1365-2249.2010.04093.x
   PubMed Web of Science ®Google Scholar
• Ohman L, Dahlen R, Isaksson S, et al. Serum IL-17A in newly diagnosed treatment-naive patients with ulcerative colitis reflects clinical disease severity and predicts the course of disease. Inflamm Bowel Dis. 2013;19(11):2433–2439. doi:10.1097/MIB.0b013e3182a563cb
   PubMed Web of Science ®Google Scholar
• Subramanian S, Ekbom A, Rhodes JM. Recent advances in clinical practice: a systematic review of isolated colonic Crohn’s disease: the third IBD? Gut. 2017;66(2):362–381. doi:10.1136/gutjnl-2016-312673
   PubMed Web of Science ®Google Scholar
• Atreya R, Siegmund B. Location is important: differentiation between ileal and colonic Crohn’s disease. Nat Rev Gastroenterol Hepatol. 2021;18(8):544–558. doi:10.1038/s41575-021-00424-6
   PubMed Web of Science ®Google Scholar
• von Stein P, Lofberg R, Kuznetsov NV, et al. Multigene analysis can discriminate between ulcerative colitis, Crohn’s disease, and irritable bowel syndrome. Gastroenterology. 2008;134(7):1869–1881. doi:10.1053/j.gastro.2008.02.083
   PubMed Web of Science ®Google Scholar
• Rosen MJ, Karns R, Vallance JE, et al. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn’s Disease in Treatment-Naive Pediatric Patients. Gastroenterology. 2017;152(6):1345–1357 e1347. doi:10.1053/j.gastro.2017.01.016
   PubMed Web of Science ®Google Scholar
• Granlund A, Flatberg A, Ostvik AE, et al. Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn’s disease and ulcerative colitis. PLoS One. 2013;8(2):e56818. doi:10.1371/journal.pone.0056818
   PubMed Web of Science ®Google Scholar
• Howell KJ, Kraiczy J, Nayak KM, et al. DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome. Gastroenterology. 2018;154(3):585–598. doi:10.1053/j.gastro.2017.10.007
   PubMed Web of Science ®Google Scholar
• Arijs I, Li K, Toedter G, et al. Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis. Gut. 2009;58(12):1612–1619. doi:10.1136/gut.2009.178665
   PubMed Web of Science ®Google Scholar
• Arijs I, Quintens R, Van Lommel L, et al. Predictive value of epithelial gene expression profiles for response to infliximab in Crohn’s disease. Inflamm Bowel Dis. 2010;16(12):2090–2098. doi:10.1002/ibd.21301
   PubMed Web of Science ®Google Scholar
• Ahluwalia B, Moraes L, Magnusson MK, Ohman L. Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies. Scand J Gastroenterol. 2018;53(4):379–389. doi:10.1080/00365521.2018.1447597
   PubMed Web of Science ®Google Scholar
• Yang L, Tang S, Baker SS, et al. Difference in Pathomechanism Between Crohn’s Disease and Ulcerative Colitis Revealed by Colon Transcriptome. Inflamm Bowel Dis. 2019;25(4):722–731. doi:10.1093/ibd/izy359
   PubMed Web of Science ®Google Scholar
• Maaser C, Sturm A, Vavricka SR, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13(2):144–164. doi:10.1093/ecco-jcc/jjy113
   PubMed Web of Science ®Google Scholar
• Eriksson L, Byrne T, Johansson E, Trygg J, Vikström C. Multi-and Megavariate Data Analysis Basic Principles and Applications. Vol. 1. Umetrics Academy; 2013.
   Google Scholar
• Yuk JM, Yoshimori T, Jo EK. Autophagy and bacterial infectious diseases. Exp Mol Med. 2012;44(2):99–108. doi:10.3858/emm.2012.44.2.032
   PubMed Web of Science ®Google Scholar
• Cadwell K. Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis. Nat Rev Immunol. 2016;16(11):661–675. doi:10.1038/nri.2016.100
   PubMed Web of Science ®Google Scholar
• Travassos LH, Carneiro LA, Ramjeet M, et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol. 2010;11(1):55–62. doi:10.1038/ni.1823
   PubMed Web of Science ®Google Scholar
• Said A, Bock S, Lajqi T, Muller G, Weindl G. Chloroquine promotes IL-17 production by CD4+ T cells via p38-dependent IL-23 release by monocyte-derived Langerhans-like cells. J Immunol. 2014;193(12):6135–6143. doi:10.4049/jimmunol.1303276
   PubMed Web of Science ®Google Scholar
• Peral de Castro C, Jones SA, Ni Cheallaigh C, et al. Autophagy regulates IL-23 secretion and innate T cell responses through effects on IL-1 secretion. J Immunol. 2012;189(8):4144–4153. doi:10.4049/jimmunol.1201946
   PubMed Web of Science ®Google Scholar
• Interleukin VM. 17 is a chief orchestrator of immunity. Nat Immunol. 2017;18(6):612–621. doi:10.1038/ni.3742
   PubMed Web of Science ®Google Scholar
• Qian Y, Kang Z, Liu C, Li X. IL-17 signaling in host defense and inflammatory diseases. Cell Mol Immunol. 2010;7(5):328–333. doi:10.1038/cmi.2010.27
   PubMed Web of Science ®Google Scholar
• Fauny M, Moulin D, D’Amico F, et al. Paradoxical gastrointestinal effects of interleukin-17 blockers. Ann Rheum Dis. 2020;79(9):1132–1138. doi:10.1136/annrheumdis-2020-217927
   PubMed Web of Science ®Google Scholar
• Zhou P, She Y, Dong N, et al. Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose. Nature. 2018;561(7721):122–126. doi:10.1038/s41586-018-0433-3
   PubMed Web of Science ®Google Scholar
• Ryzhakov G, West NR, Franchini F, et al. Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/Th1 axis. Nat Commun. 2018;9(1):3797. doi:10.1038/s41467-018-06085-5
   PubMed Web of Science ®Google Scholar
• Sun CC, Zhou ZQ, Yang D, et al. Recent advances in studies of 15-PGDH as a key enzyme for the degradation of prostaglandins. Int Immunopharmacol. 2021;101(Pt B):108176. doi:10.1016/j.intimp.2021.108176
   PubMed Web of Science ®Google Scholar
• Norwood S, Liao J, Hammock BD, Yang GY. Epoxyeicosatrienoic acids and soluble epoxide hydrolase: potential therapeutic targets for inflammation and its induced carcinogenesis. Am J Transl Res. 2010;2(4):447–457.
   PubMed Web of Science ®Google Scholar
• Mashima R, Okuyama T. The role of lipoxygenases in pathophysiology; new insights and future perspectives. Redox Biol. 2015;6:297–310. doi:10.1016/j.redox.2015.08.006
   PubMed Web of Science ®Google Scholar
• Lampinen M, Ronnblom A, Amin K, et al. Eosinophil granulocytes are activated during the remission phase of ulcerative colitis. Gut. 2005;54(12):1714–1720. doi:10.1136/gut.2005.066423
   PubMed Web of Science ®Google Scholar
• Lampinen M, Backman M, Winqvist O, et al. Different regulation of eosinophil activity in Crohn’s disease compared with ulcerative colitis. J Leukoc Biol. 2008;84(6):1392–1399. doi:10.1189/jlb.0807513
   PubMed Web of Science ®Google Scholar
• Wallon C, Persborn M, Jonsson M, et al. Eosinophils express muscarinic receptors and corticotropin-releasing factor to disrupt the mucosal barrier in ulcerative colitis. Gastroenterology. 2011;140(5):1597–1607. doi:10.1053/j.gastro.2011.01.042
   PubMed Web of Science ®Google Scholar
• Katinios G, Casado-Bedmar M, Walter SA, et al. Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health. Inflamm Bowel Dis. 2020;26(7):974–984. doi:10.1093/ibd/izz328
   PubMed Web of Science ®Google Scholar
• Fandriks L. The renin-angiotensin system and the gastrointestinal mucosa. Acta Physiol. 2011;201(1):157–167. doi:10.1111/j.1748-1716.2010.02165.x
   PubMed Web of Science ®Google Scholar
• Salmenkari H, Korpela R, Vapaatalo H. Renin-angiotensin system in intestinal inflammation-Angiotensin inhibitors to treat inflammatory bowel diseases? Basic Clin Pharmacol Toxicol. 2021;129(3):161–172. doi:10.1111/bcpt.13624
   PubMed Web of Science ®Google Scholar
• Shi Y, Liu T, He L, et al. Activation of the Renin-Angiotensin System Promotes Colitis Development. Sci Rep. 2016;6:27552. doi:10.1038/srep27552
   PubMed Web of Science ®Google Scholar
• Vargas F, Wangesteen R, Rodriguez-Gomez I, Garcia-Estan J. Aminopeptidases in Cardiovascular and Renal Function. Role as Predictive Renal Injury Biomarkers. Int J Mol Sci. 2020;21(16):548. doi:10.3390/ijms21165615
   PubMed Web of Science ®Google Scholar